Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
1(9%)
Results Posted
29%(2 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_4
1
9%
Ph phase_2
5
45%
Ph not_applicable
4
36%
Ph early_phase_1
1
9%

Phase Distribution

1

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 2Efficacy & side effects
5(45.5%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
4(36.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(7)
Terminated(2)

Detailed Status

Completed7
Not yet recruiting1
Recruiting1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (9.1%)
Phase 25 (45.5%)
Phase 41 (9.1%)
N/A4 (36.4%)

Trials by Status

not_yet_recruiting19%
recruiting19%
withdrawn19%
terminated19%
completed764%

Recent Activity

1 active trials
Showing 5 of 11
recruitingphase_2

Reducing Frailty for Older Cancer Survivors Using Supplements II

NCT06068543
withdrawnphase_2

Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease

NCT01125449
not_yet_recruitingphase_4

Prevention and Treatment for Bruises in Patients with Ischemic Stroke

NCT06823999
completednot_applicable

Influence of Endothelial Function on Central and Peripheral Causes Of Exercise Impairment in Type 2 Diabetes

NCT00786019
completedearly_phase_1

Local Vasoconstriction in Postural Tachycardia Syndrome

NCT01210430
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06068543Phase 2

Reducing Frailty for Older Cancer Survivors Using Supplements II

Recruiting
NCT01125449Phase 2

Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease

Withdrawn
NCT06823999Phase 4

Prevention and Treatment for Bruises in Patients with Ischemic Stroke

Not Yet Recruiting
NCT00786019Not Applicable

Influence of Endothelial Function on Central and Peripheral Causes Of Exercise Impairment in Type 2 Diabetes

Completed
NCT01210430Early Phase 1

Local Vasoconstriction in Postural Tachycardia Syndrome

Completed
NCT00845130Not Applicable

Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes

Completed
NCT01080352Phase 2

Vitamin C as an Anti-cancer Drug

Completed
NCT00484510Phase 2

High Dose Ascorbic Acid Treatment of CMT1A

Completed
NCT01250743Not Applicable

A Pilot Study of High-Dose, Intravenous Ascorbic Acid (Vitamin C) to Treat Hepatitis C

Terminated
NCT00633581Phase 2

Efficacy of Vitamin C Injection on Fatigue in Workers After Work

Completed
NCT00624871Not Applicable

Ascorbic Acid and Ibuprofen in Infants With Hypoxic Ischemic Encephalopathy

Completed

All 11 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
11